Showing results (121-130 of 468) with videos related to
Sort By:
Pageof 47
Clinical Colorectal Cancer|October 12, 2016
Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal CancerBen Y Zhang, Jeremy C Jones, Andrew M Briggler, et al.Breast Cancer Research and Treatment|October 25, 2023
Nodal pCR and overall survival following neoadjuvant chemotherapy for node positive ER+/Her2- breast cancerDan Moldoveanu, Tanya L Hoskin, Courtney N Day, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 16, 2019
Case series of dabrafenib-trametinib-induced pyrexia successfully treated with colchicineJesus Vera, Jonas Paludo, Lisa Kottschade, et al.Annals of Surgical Oncology|July 17, 2023
Clinical Behavior, Management, and Treatment Response of Estrogen Receptor Low (1-10%) Breast CancerDan Moldoveanu, Tanya L Hoskin, Courtney N Day, et al.The Oncologist|July 9, 2011
KRAS and colorectal cancer: ethical and pragmatic issues in effecting real-time change in oncology clinical trials and practiceCharles D Blanke, Richard M Goldberg, Axel Grothey, et al.European Journal of Cancer (Oxford, England : 1990)|September 6, 2020
A new prognostic and predictive tool for shared decision making in stage III colon cancerAlberto F Sobrero, Alberto Puccini, Qian Shi, et al.International Journal of Statistics in Medical Research|August 10, 2019
Combining Survival and Toxicity Effect Sizes from Clinical Trials: NCCTG 89-20-52 (Alliance)Brittny T Major-Elechi, Paul J Novotny, Jasvinder A Singh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2013
Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance)Charles L Loprinzi, Rui Qin, Shaker R Dakhil, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 8, 2015
MC11C4: a pilot randomized, placebo-controlled, double-blind study of venlafaxine to prevent oxaliplatin-induced neuropathyCollin Zimmerman, Pamela J Atherton, Deirdre Pachman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2008
Response-independent survival benefit in metastatic colorectal cancer: a comparative analysis of N9741 and AVF2107Axel Grothey, Eric E Hedrick, Robert D Mass, et al.Pageof 47